Coloplast announced it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to “strategically strengthen [its] presence in the advanced ...
Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...
Coloplast is growing with extreme consistency and first quarter results were in-line again with previous top line growth. The company is not only growing with high consistency but also has extremely ...
Ladies and gentlemen, welcome to the Coloplast A/S Q1 2024-'25 Earnings Release Conference Call. I'm Valentina, the Chorus Call operator. [Operator Instructions] The conference must not be recorded ...
Though inflationary pressures have been alleviated to some extent, Coloplast’s ongoing launches of key new products should damp operating margin until fiscal 2026. After taking another look at how ...
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results